
70岁香港男子接受开创性组织碎化术后无痛返家,该技术利用聚焦声波瞄准肿瘤,无需开刀。
70-year-old Hongkonger returns home pain-free after pioneering histotripsy procedure that uses focused sound waves to target tumours without surgery.
患者李声贤(音)在薄扶林香港大学李嘉诚医学院举行的亚洲首例组织碎化技术治疗肾癌媒体简报会上。 “感觉像什么都没发生一样”,术后没有伤口也没有疼痛,当晚就能正常吃饭。
Patient Li Sing-yan at a media briefing on Asia’s first histotripsy treatment for kidney cancer at the LKS Faculty of Medicine in Pok Fu Lam. Photo: Warton Li Hongkonger Li Sing-yan has recalled how he “felt like nothing happened” on the day he became one of Asia’s first two kidney cancer patients to receive an incision-free procedure that left him with no wounds or pain, enabling him to eat normal meals by that evening.
这项前沿技术名为组织碎化术,利用聚焦声波击碎肿瘤,无需手术切口。
The cutting-edge technique, called histotripsy, uses focused sound waves to break apart tumours without surgical incisions.
过去两年,这项无创医疗技术已在香港用于治疗400多名肝癌和胰腺癌患者,如今开始用于治疗肾癌。
The non-invasive medical procedure has already been used to treat more than 400 patients with liver and pancreatic cancers in Hong Kong over the past two years and is now being used to target kidney cancer.
70岁的李声贤三个月前发现肾脏上有一个小肿瘤。他10年前曾接受过肝胆胰系统的大手术,因此考虑放弃这次手术。“我已经老了,不能再经历一次开腹手术了,”他说。
After discovering a small tumour on his kidney three months ago, Li, 70, who had undergone major abdominal surgery on his hepatobiliary and pancreatic system 10 years ago, considered skipping the operation. “I’m already old and can’t go through another open surgery again,” he said.
李声贤随后于10月13日在香港港安医院接受组织碎化术,治疗用时不到一小时。次日复查MRI扫描显示肿瘤空化效果良好,他没有伤口,也未出现可观察到的并发症,随后出院。
Li later underwent the histotripsy procedure at Gleneagles Hospital Hong Kong on October 13, with the treatment taking less than an hour. He was discharged after a follow-up MRI scan the next day showed good tumour cavitation, with no wounds or observable complications.
“手术当天我感觉像什么都没发生。到晚上就能正常吃饭,之后也不痛,只是头两天尿里有血,”李声贤回忆说,并补充道他在恢复一个月后就恢复了运动习惯。
“I felt like nothing happened on the day of the surgery. I could eat normal meals by evening, and there was no pain afterwards, just some blood in my urine in the first two days,” Li recalled, adding that he was able to resume his sports routine after a month of recovery.

李先生说:“之前做过一次大手术,让我知道那有多痛。用组织碎化技术,真的没有切口。它确实帮到了我。”研究团队表示,这项治疗由香港大学李嘉诚医学院(港大医学院)的团队与香港港安医院合作进行,是亚洲首次将组织碎化技术用于肾癌治疗。
“Having undergone a major surgery before makes me know how painful it could be,” Li said. “With histotripsy, there is really no incision. It really helped me.”The treatment was performed by a team from the University of Hong Kong’s Li Ka Shing Faculty of Medicine (HKUMed) in collaboration with Gleneagles Hospital Hong Kong, marking the first use of histotripsy for kidney cancer in Asia, according to the research team.
李嘉诚基金会早前宣布,中大医院、香港港安医院及香港养和医院将开展涉及共30名患者的试验,以评估组织碎化技术的安全性和有效性。
The Li Ka Shing Foundation earlier announced that CUHK Medical Centre, Gleneagles Hospital Hong Kong and Hong Kong Sanatorium & Hospital would conduct trials involving 30 patients in total to assess the safety and efficacy of histotripsy.
港大医学院正与香港港安医院合作开展一项临床试验,涉及15名局部肾细胞癌患者。肾细胞癌是一种常见的早期肾癌。参与试验的患者治疗免费。
HKUMed is collaborating with Gleneagles Hospital Hong Kong on a clinical trial involving 15 patients with localised renal cell carcinoma (RCC), a common type of early-stage kidney cancer. Treatment for patients in the trial is free.
过去十年,香港的肾癌病例有所上升。根据香港癌症资料统计中心的数据,2023年男性中新发肾癌及除膀胱外其他泌尿器官癌症病例共598例,粗发病率为每10万名男性17.4例,是男性第七大常见癌症。
Kidney cancer cases in Hong Kong have risen over the past decade. In 2023, there were 598 new cases of kidney cancer and cancers of other urinary organs excluding the bladder among men, with a crude incidence rate of 17.4 per 100,000 males, making it the seventh most common cancer among men, according to the Hong Kong Cancer Registry.
虽然切除部分或全部肾脏的手术仍是局部肾癌的主要治疗方法,但港大医学院外科学系临床助理教授、该研究泌尿科负责人梁崇礼医生说,组织碎化技术“对部分肾细胞癌患者来说是一种可能有价值的治疗选择”。
While surgery to remove part or all of the kidney remains the main treatment for localised kidney cancer, Dr John Leung Shung-lai, clinical assistant professor in HKUMed’s Department of Surgery and the study’s urology lead, said histotripsy “is a potentially valuable treatment option for selected patients with RCC”.
“其主要优点是不涉及任何皮肤切口,患者可以迅速恢复正常活动。”梁崇礼说,当天与李先生一同在港安医院接受治疗的第二名患者是一名71岁女性早期肾癌患者,她也在一小时内完成治疗,并于次日出院。
“Its main advantages are that it does not involve any skin incisions and allows patients to return to normal activities quickly.”Leung said the second patient treated on the same day with Li at Gleneagles Hospital was a 71-year-old woman with early-stage kidney cancer who also completed treatment within an hour and was discharged the following day.
一个月的随访检查显示,两名患者的治疗区域均精准覆盖了肿瘤,研究团队表示,肿瘤将在组织消融术后随时间逐渐缩小,将对周围肾组织的影响降至最低。
One-month follow-up checks showed that the treatment zones of both patients accurately covered their tumours, which would gradually shrink over time after histotripsy, minimising the impact on surrounding kidney tissue, the research team said.
梁医生说:“但必须指出,组织消融术治疗肾癌仍处于研究阶段。”他补充说,目前的试验聚焦于早期肾癌患者,仍需进一步随访以评估其长期效果。
“However, it is important to note that histotripsy for kidney cancer is still investigational,” Leung said, adding that the current trial focused on patients with early-stage kidney cancer, and further follow-up was needed to assess its long-term effects.
文:Lexi Tian 版块:新闻 / 香港 / 健康与环境 | 专题:香港医疗与医院、香港、香港社会、香港癌症治疗、香港科技短链接:
By Lexi Tian Sections: News / Hong Kong / Health & Environment | Topics: Hong Kong healthcare and hospitals, Hong Kong, Hong Kong society, Hong Kong cancer therapy, Hong Kong science and technology Short link: